Last reviewed · How we verify

NCT06079606

The Effects of Antibiotic Exposure in Early Infancy on Vaccine Responses

Active, enrolled Last updated 18 December 2025
What this trial tests

trial testing Antibiotic treatment in Immune Responses in 200 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
10 September 2022
Primary endpoint
28 February 2025
31 December 2027

Quick facts

Lead sponsorLandspitali University Hospital
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment200
Start date10 September 2022
Primary completion28 February 2025
Estimated completion31 December 2027
Sites1 location across Iceland

Drugs / interventions tested

Conditions studied

Sponsor

Landspitali University Hospital

Who can join

Under 6 Weeks, any sex, with Immune Responses or Antibiotic Treatment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective cohort study will include 200 term children born in Landspitali University Hospital in Iceland. The cohort will be divided into four groups according to antibiotic exposure of which one is the control group. Children's immune responses to live oral rotavirus vaccine as well as conventional vaccinations given at three, five and 12 months old will be determined by measuring salivary and serologic responses. Responses will be compared between the four groups. Stool samples will also be collected from participants and the composition of the microbiome compared between the four groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Antibiotic treatment

Trials testing the same drug.

Other Landspitali University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06079606.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing